|

Integration of Stepped Care for Perinatal Mood and Anxiety Disorders Among Women Attending MCH Clinics

RECRUITINGN/ASponsored by Kenyatta National Hospital
Actively Recruiting
PhaseN/A
SponsorKenyatta National Hospital
Started2025-02-17
Est. completion2028-03
Eligibility
Age14 Years+
SexFEMALE
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06456307

Summary

Perinatal mood and anxiety disorders (PMAD), defined as depression and anxiety during pregnancy or up to 1 year postpartum, account for substantial morbidity and mortality among birthing people globally especially in low- and middle-income countries. Several evidence-based interventions are recommended for identification and management of PMAD by non-specialist providers in resource-limited settings. This cluster-randomized trial seeks to evaluate the effect of a stepped-care intervention for screening and treatment of PMAD among perinatal women, on clinical and implementation outcomes.

Eligibility

Age: 14 Years+Sex: FEMALEHealthy volunteers accepted
Inclusion Criteria:

* Pregnant and ≥28 weeks gestation
* Attending ANC care at the facility
* ≥14 years old
* Screen positive for PMAD symptoms (PHQ-2≥3 and/or GAD-2≥3)
* Willing to return to the MCH and PMTCT clinic for study visits

Exclusion Criteria:

* Less than 28 weeks gestation
* Any woman at high risk of self-harm based on a study self-harm assessment protocol,
* Has cognitive impairments or psychotic symptoms

Conditions5

Antenatal DepressionAnxietyDepressionDepression, AnxietyPostnatal Depression

Browse More Trials

Depression trialsAnxiety trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.